Evidence map›Paper›PMID 27606595›Full record

ArticlePloS one2016

Yersinia pestis Caf1 Protein: Effect of Sequence Polymorphism on Intrinsic Disorder Propensity, Serological Cross-Reactivity and Cross-Protectivity of Isoforms.

Pavel Kh Kopylov, Mikhail E Platonov, Vitaly G Ablamunits, Tat'yana I Kombarova, Sergey A Ivanov, Lidiya A Kadnikova, Aleksey N Somov, Svetlana V Dentovskaya, Vladimir N Uversky, Andrey P Anisimov

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact, top 92% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. International journal of molecular sciences · 2023
    Article
  3. Review
  4. Article
  5. Article
  6. Biomolecules · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Pavel Kh KopylovState Research Center for Applied Microbiology and Biotechnology, Obolensk, Moscow Region, Russia.
Mikhail E PlatonovState Research Center for Applied Microbiology and Biotechnology, Obolensk, Moscow Region, Russia.
Vitaly G AblamunitsSaint Petersburg Medical Pediatric University, Saint Petersburg, Russia.
Tat'yana I KombarovaState Research Center for Applied Microbiology and Biotechnology, Obolensk, Moscow Region, Russia.
Sergey A IvanovState Research Center for Applied Microbiology and Biotechnology, Obolensk, Moscow Region, Russia.
Lidiya A KadnikovaState Research Center for Applied Microbiology and Biotechnology, Obolensk, Moscow Region, Russia.
Aleksey N SomovState Research Center for Applied Microbiology and Biotechnology, Obolensk, Moscow Region, Russia.
Svetlana V DentovskayaState Research Center for Applied Microbiology and Biotechnology, Obolensk, Moscow Region, Russia.
Vladimir N UverskyDepartment of Molecular Medicine and Byrd Alzheimer's Research Institute, Morsani College of Medicine, University of South Florida, Tampa, Florida, United States of America.
Andrey P AnisimovState Research Center for Applied Microbiology and Biotechnology, Obolensk, Moscow Region, Russia.ORCID http://orcid.org/0000-0002-5499-7999
State Research Center for Applied Microbiology and Biotechnology · RUSaint Petersburg State Pediatric Medical University · RUUniversity of South Florida · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Yersinia pestis Caf1 is a multifunctional protein responsible for antiphagocytic activity and is a key protective antigen. It is generally conserved between globally distributed Y. pestis strains, but Y. pestis subsp. microtus biovar caucasica strains circulating within populations of common voles in Georgia and Armenia were reported to carry a single substitution of alanine to serine. We investigated polymorphism of the Caf1 sequences among other Y. pestis subsp. microtus strains, which have a limited virulence in guinea pigs and in humans. Sequencing of caf1 genes from 119 Y. pestis strains belonging to different biovars within subsp. microtus showed that the Caf1 proteins exist in three isoforms, the global type Caf1NT1 (Ala48 Phe117), type Caf1NT2 (Ser48 Phe117) found in Transcaucasian-highland and Pre-Araks natural plague foci #4-7, and a novel Caf1NT3 type (Ala48 Val117) endemic in Dagestan-highland natural plague focus #39. Both minor types are the progenies of the global isoform. In this report, Caf1 polymorphism was analyzed by comparing predicted intrinsic disorder propensities and potential protein-protein interactivities of the three Caf1 isoforms. The analysis revealed that these properties of Caf1 protein are minimally affected by its polymorphism. All protein isoforms could be equally detected by an immunochromatography test for plague at the lowest protein concentration tested (1.0 ng/mL), which is the detection limit. When compared to the classic Caf1NT1 isoform, the endemic Caf1NT2 or Caf1NT3 had lower immunoreactivity in ELISA and lower indices of self- and cross-protection. Despite a visible reduction in cross-protection between all Caf1 isoforms, our data suggest that polymorphism in the caf1 gene may not allow the carriers of Caf1NT2 or Caf1NT3 variants escaping from the Caf1NT1-mediated immunity to plague in the case of a low-dose flea-borne infection.

Indexed as

Polymorphism, GeneticPropensity ScoreAmino Acid SequenceAnimalsAntigens, BacterialBacterial ProteinsCross ReactionsFemaleImmunityImmunizationIntrinsically Disordered ProteinsMice, Inbred BALB CProtein IsoformsSequence AlignmentVirulenceYersinia pestisAntigens, BacterialBacterial Proteinscaf1 protein, Yersinia pestisIntrinsically Disordered ProteinsProtein Isoforms

Identifiers

PMID27606595
PMCPMC5015843
OpenAlexW2515440774

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.